![](/img/cover-not-exists.png)
Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1
Traboulsee, Anthony, Li, David K. B., Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, AaronVolume:
18
Language:
english
Journal:
BMC Neurology
DOI:
10.1186/s12883-018-1145-x
Date:
December, 2018
File:
PDF, 1022 KB
english, 2018